Franziska Olm

Franziska Olm is a translational researcher in regenerative medicine and lung transplantation at Lund University, Sweden. Her work focuses on developing and translating next-generation cell and gene therapies to improve donor organ quality and long-term transplant outcomes.

She obtained her MSc in Biotechnology from the Technical University of Berlin and her PhD in Medical Sciences (Stem Cell Biology and Biomedical Engineering) from Lund University. Her scientific expertise spans advanced therapy medicinal products (ATMPs), ex vivo organ perfusion, mitochondrial transplantation, and large-animal models for translational research, as well as clinical research.

Franziska has established an independent and multidisciplinary research profile at the interface between experimental and clinical science. She leads and contributes to national and international collaborations advancing regenerative and immunomodulatory approaches in transplantation. Her work is supported by competitive grants and combines academic, clinical, and industrial perspectives to accelerate clinical translation.

Beyond research, she is actively engaged in mentorship, teaching, and academic service. She contributes to institutional initiatives on diversity, equity, and sustainability, and is committed to fostering interdisciplinary collaboration and supporting early-career scientists.

As a member of the ECTORS Board (2025–2029), Franziska is dedicated to promoting innovation, education, and collaboration in regenerative transplantation. She aims to strengthen the scientific activities of ECTORS and contribute to advancing cell and gene therapies for organ repair and immune modulation.